Mark Oliver

Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators.

Carla Colombo, Grant A Ramm, Anders Lindblad, Fabiola Corti, Luigi Porcaro, Federico Alghisi, Irina Asherova, Helen Evans, Nataliya Kashirskaya, Elena Kondratyeva, Peter J Lewindon, Isabelle de Monestrol, Mark Oliver, Chee Y Ooi, Rita Padoan, Sahana Shankar, Gianfranco Alicandro

Journal article  |  2023  |  J Cyst Fibros

Cystic-fibrosis-related liver disease (CFLD) is a variable phenotype of CF. The severe CFLD variant with cirrhosis or portal hyper..

Prevalence of irritable bowel syndrome and functional abdominal pain disorders in children with inflammatory bowel disease in remission.

Lydia F Limbri, Thomas G Wilson, Mark R Oliver

Journal article  |  2022  |  JGH Open

Despite evidence of an increased prevalence of irritable bowel syndrome (IBS) in adults with inflammatory bowel disease (IBD) comp..

Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study.

Carla Colombo, Gianfranco Alicandro, Mark Oliver, Peter J Lewindon, Grant A Ramm, Chee Y Ooi, Federico Alghisi, Nataliya Kashirskaya, Elena Kondratyeva, Fabiola Corti, Rita Padoan, Irina Asherova, Helen Evans, Isabelle de Monestrol, Birgitta Strandvik, Anders Lindblad, undefined CF UDCA study group

Journal article  |  2022  |  J Cyst Fibros

BACKGROUND: The efficacy and safety of ursodeoxycholic acid (UDCA) for the treatment of liver disease associated with cystic fibro..

Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females

Kathryn Clarkston, Joy Lee, Sarah Donoghue, Heidi Peters, Hernan Eiroa, Amit A Shah, Kathleen Loomes, Jessica Wen, Mark Oliver, Winita Hardikar, Carlos E Prada, Akihiro Asai

Journal article  |  2020  |  AMERICAN JOURNAL OF MEDICAL GENETICS PART A

We describe 10 females with ornithine transcarbamylase (OTC) deficiency and liver dysfunction, revealing a unique pattern of hepat..

Paediatric constipation for general paediatricians: Review using a case-based and evidence-based approach

Rishi Bolia, Mark Safe, Bridget R Southwell, Sebastian K King, Mark R Oliver

Journal article  |  2020  |  JOURNAL OF PAEDIATRICS AND CHILD HEALTH

Constipation is a common problem in childhood. The most common type of constipation is functional, accounting for 90-95% of all ca..

Microarray diagnosis of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy caused by a novel homozygous intragenic AIRE deletion

Lauren S Akesson, David Francis, Michelle de Silva, Theresa Cole, Peter Simm, Mark Oliver, Susan M White

Journal article  |  2020  |  JOURNAL OF PAEDIATRICS AND CHILD HEALTH

WS03.2 A multicentre cohort study on ursodeoxycholic acid and liver disease associated with cystic fibrosis

C Colombo, G Alicandro, H Evans, M Oliver, CY Ooi, F Alghisi, N Kashirskaya, E Kondratyeva, G Ramm, I de Monestrol, R Padoan, I Asherova, A Lindblad

Journal article  |  2020  |  Journal of Cystic Fibrosis

Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease.

Shivani Kansal, Anthony G Catto-Smith, Karen Boniface, Sarah Thomas, Donald J Cameron, Mark Oliver, George Alex, Carl D Kirkwood, Josef Wagner

Journal article  |  2019  |  J Pediatr Gastroenterol Nutr

OBJECTIVES: Crohn disease (CD) is a chronic relapsing condition possibly caused by a dysbiotic microbiome. Approximately 30% to 60..

Variation of Gut Mucosal Microbiome With Anti-Saccharomyces cerevisiae Antibody Status in Pediatric Crohn Disease

Shivani Kansal, Anthony G Catto-Smith, Karen Boniface, Sarah Thomas, Donald J Cameron, Mark Oliver, George Alex, Carl D Kirkwood, Josef Wagner

Journal article  |  2019  |  JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

OBJECTIVES: Crohn's Disease (CD) is a chronic relapsing condition possibly caused by a dysbiotic microbiome. About 30-60% of CD pa..

The Microbiome in Paediatric Crohn's Disease-A Longitudinal, Prospective, Single-Centre Study

Shivani Kansal, Anthony G Catto-Smith, Karen Boniface, Sarah Thomas, Donald J Cameron, Mark Oliver, George Alex, Carl D Kirkwood, Josef Wagner

Journal article  |  2019  |  JOURNAL OF CROHNS & COLITIS

BACKGROUND AND AIMS: The gut mucosa is the principal site where Crohn's disease [CD] inflammation occurs. Limited information is a..